Bioanalysis has contributed substantially to PRU/APIC leading position as an internationally recognized CRO
Our laboratories have the capability to develop and validate analytical methods for a variety of drug substances and metabolites using sophisticated high-throughput technologies. PRU/APIC utilizes a wide range of techniques available for bioanalysis, e.g., LC-MS/MS, LC-MS, and UPLC.
Our qualified and trained chemists with years of experience in analytical laboratories are distributed into multiple teams, and this enables the handling of multiple projects at the same time. With the capacity to conduct more than 80 BE/ BA/ PK studies per year while adhering to the highest quality standards and in accordance with GLP and international regulations; we have developed and validated more than 250 analytical methods and the list increases daily.
Our research center is specialized in developing and validating new analytical methods of analysis for drug products and its staff of analytical professionals are delivering consultation wherever required. This research center is aiming to create and improve analytical procedures throughout a wide range of modern instrumental techniques.
Our analytical team is one of the most effective team players with critical thinking, capability of handling tough projects with highest quality standards and meeting deadlines.
Our Qualified analytical team complies in full with the latest EMA and FDA Guideline on bioanalytical method validation and analysis, GLP and GCP. The team gains effective training and acquires sufficient knowledge from experts, trainers and auditors who are continuously enriching the analytical cycle.
Analytical teams are distributed into two groups; bio-analytical analysts and QC team. The QC team focuses on auditing the work process during all phases, as per international guidelines.
